Logo image
Interpreting angiogenic biomarkers profiles in pregestational diabetes as markers of fetal risk (reply to letter-to-the-editor)
Letter/Communication   Peer reviewed

Interpreting angiogenic biomarkers profiles in pregestational diabetes as markers of fetal risk (reply to letter-to-the-editor)

Ruth C E Hughes, Jonathan A Williman and Gene Lee
American journal of obstetrics and gynecology
23/09/2026
Handle:
https://hdl.handle.net/10523/52707

Abstract

Letter to the Editor Authors' reply
Authors' reply to Letter to the Editor: Chen, Y., Li, J., & Ye, T. (2026). Interpreting the diagnostic performance of angiogenic biomarkers in pregestational diabetes (Letter-to-the-Editor). American journal of obstetrics and gynecology, https://doi.org/10.1016/j.ajog.2026.09.035, regarding their article: Hughes, R. C. E., Williman, J. A., Lee, G., & Mackay, D. (2026). Abnormal serum sFlt-1 and PlGF as markers of occult placental dysfunction and fetal risk in pregestational diabetes: A Prospective Masked Cohort Study. American Journal of Obstetrics and Gynecology, https://doi.org/10.1016/j.ajog.2026.07.026.

Metrics

1 Record Views

Details

Logo image